Challenges for China's E-Cigarette Export to Russia

Mar.03.2022
Challenges for China's E-Cigarette Export to Russia
Russia is China's third-largest e-cigarette export market, facing challenges due to the ongoing conflict with Ukraine.

Russia is currently China’s third largest export market for electronic cigarettes, according to the “2021 Electronic Cigarette Industry Blue Book” published by the Electronic Cigarette Industry Committee of the China Electronic Commerce Association and Juul Labs. The report reveals that in 2021, China’s electronic cigarette industry is projected to export about 138.3 billion yuan, up 180% from the previous year. The top four countries and regions for electronic cigarette exports are the United States, the European Union, Russia, and the United Kingdom, accounting for 53%, 15%, 9%, and 7% respectively.

 

With the ongoing conflict between Russia and Ukraine, China's export of electronic cigarettes to Russia is facing multiple challenges.

 

The impact of SWIFT sanctions on settlements is limited.

 

The ongoing conflict between Russia and Ukraine, as well as Russia's relationship with Western powers, is increasingly tense. On February 27th, the United States, European Union, and United Kingdom announced sanctions against the 10 largest financial institutions in Russia through the SWIFT system. The crisis has resulted in an atmosphere of great international tension.

 

Although some Russian banks may be excluded from SWIFT, the impact on the industry is not significant. Several e-cigarette foreign trade practitioners have stated that their company's export settlement has not been affected by SWIFT sanctions. They said that their company's clients usually open accounts in foreign banks in Russia, exchange rubles for dollars within Russia, and use dollars to complete payments. Currently, this business is continuing.

 

Ruble depreciation leads to order cancellations.

 

However, the devaluation of the ruble has had a more serious impact on the trade of electronic cigarettes between China and Russia. According to information obtained by "2FIRSTS", a vast majority of Chinese e-cigarette exporters have reported significant effects. Recently, there has been a great deal of volatility in Russia's financial markets. On February 24th, the Russian RTS index plummeted by over 50%, dropping to 611.95 points, while the MOEX index fell by more than 45%.

 

The Russian ruble experienced a significant depreciation, causing a surge in key energy commodities including oil and natural gas on February 28th. The off-shore exchange rate for the ruble against the US dollar also plummeted nearly 30%.

 

According to 2FIRSTS, Chinese exporters have stated that the devaluation of the ruble has caused immense pressure on Russian e-cigarette importers, with costs skyrocketing overnight. Faced with these huge cost pressures, a large proportion of importers have been forced to cancel their foreign trade orders for Chinese e-cigarettes. Importers are unlikely to engage in bulk order transactions until the ruble exchange rate improves.

 

This change has caught the market off guard. Prior to the recent conflict between Ukraine and Russia, the Chinese e-cigarette industry expected exports to Russia to increase by 50-100% this year. However, the unexpected event has had a significant impact. If the conflict persists, it is estimated that the Russian market will perform worse than last year, and the entire market will stagnate.

 

There could be ongoing disruptions to Grey's logistics.

 

Chinese e-cigarette exporters are facing significant difficulties in exporting to Russia due to challenging customs clearance procedures. Prior to the conflict between Russia and Ukraine, e-cigarettes from China would typically be cleared through a grey customs clearance process, meaning they would first arrive in Russian-speaking countries surrounding Russia, go through customs there, and then be transported into Russia. However, in the current geopolitical climate, logistics and border controls are much stricter, making grey customs channels between China and Russia less accessible.

 

Currently, the electronic cigarette market in Russia is not experiencing any shortage pressures, as distributors typically hold a three-month inventory. The impact of logistics disruptions has not yet been felt by consumers, and there have been no reports of significant price increases.

 

The dispute between Russia and Ukraine is unlikely to be resolved to everyone's satisfaction in the short term, and western sanctions against Russia will continue. This will present various inconveniences for the export of Chinese e-cigarettes to the Russian market. While the battlefield may be constantly changing, the fundamentals of supply and demand have not shifted. In the long term, the Chinese e-cigarette industry can still keep an eye on the Russian market and wait for trade to return to normal.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
Special Report | China Opens Draft Mandatory Heated Cigarette Standard for Comment, Multiple Heating Technologies Remain in Scope
Special Report | China Opens Draft Mandatory Heated Cigarette Standard for Comment, Multiple Heating Technologies Remain in Scope
China’s State Tobacco Monopoly Administration (STMA) has released a draft mandatory national standard for heated cigarettes, setting out detailed requirements for tobacco sticks, heating devices and aerosols. The proposal treats the stick and device as parts of the same product system, focuses on minimum safety and quality requirements, and leaves several heating architectures within scope.
Special Report
Jul.29
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11